Monopar (MNPR) Director Raymond Anderson Exercises Options, Sells Shares

What Happened Raymond Anderson, a director of Monopar Therapeutics (MNPR), exercised options to acquire a total of 3,142 shares (1,402 and 1,740 shares) at an exercise price of $30.00 each (total exercise cost $94,260). On the same day (Aug 25, 2026) he sold those 3,142 shares in three open‑market transactions, generating approximately $351,835 in gross proceeds (694 shares at $110.04; 646 shares at $111.07; 1,802 shares at $113.05 — reported as weighted averages).

Key Details

• Transaction date: August 25, 2026 (reported on an amended Form 4 filed Aug 28, 2026).
• Option exercises: 1,402 and 1,740 shares at $30.00 each (total $94,260).
• Open‑market sales: 694 shares @ $110.04 ($76,368), 646 shares @ $111.07 ($71,751), 1,802 shares @ $113.05 ($203,716); total ≈ $351,835.
• Shares owned after transaction: not disclosed in the provided excerpt.
• Footnotes: Transactions were effected pursuant to a Rule 10b5‑1 trading plan (Plan executed May 26, 2026). Price entries for sales are weighted averages; ranges for the underlying trades are provided in the filing (see F4–F6). Option grants originating in 2017 and 2018 and their vesting schedules are noted in the filing.
• Filing status: This is an amended Form 4. The prior Form 4 (filed Aug 27, 2026) inadvertently omitted the two option exercises and did not account for Monopar’s 5-for-1 reverse stock split (effective Aug 12, 2024). The amendment corrects those omissions — the filing was therefore late/amended.

Context

• Derivative explanation: The reported "M" transactions are option exercises — the director converted vested options into common shares and then sold those shares. Because the exercises and sales occurred under a preplanned 10b5‑1 plan, the trades were likely scheduled in advance rather than timed ad hoc.
• For retail investors: sales following option exercises are common and can be routine (e.g., to cover exercise costs, taxes, or diversify). The amendment and reverse‑split adjustment are administrative corrections to prior reporting; they do not by themselves indicate a change in company fundamentals.